In English | En español
Questions About Cancer? 1-800-4-CANCER

Find News Releases

Search For:
Between these dates:

Page Options

  • Print This Page
  • Email This Document
News from NCI
  • Black and white microscope image of human lymphocyte, which appears as a white ball with tendrils branching off from the surface.
    NIH study uncovers likely role of major cancer protein
    NIH Press Release

    (Posted: 09/27/2012) - Scientists may have discovered why a protein called MYC can provoke a variety of cancers. Like many proteins associated with cancer, MYC helps regulate cell growth. A study carried out by researchers at NIH and colleagues found that, unlike many other cell growth regulators, MYC does not turn genes on or off, but instead boosts the expression of genes that are already turned on.

  • Microscopic view of breast cancer cells with cell nuclei stained blue and dots responding to overproduction of the HER2 protein lit up in bright red
    Study reveals genomic similarities between breast and ovarian cancers
    NIH Press Release

    (Posted: 09/24/2012) - A new study from The Cancer Genome Atlas captured a complete view of genomic alterations in breast cancer and classified them into four intrinsic subtypes, one of which shares many genetic features with high-grade serous ovarian cancer. Depicted are breast cancer cells with the HER2 protein, which can trigger cell growth responses, lit up in bright red. (Photo credit: NIST)

  • Head shot color photo of NCI director Harold Varmus
    What Impedes Cancer Research?: NCI Director Harold Varmus to address National Press Club
    Press Opportunity

    (Posted: 09/21/2012) - The barriers that impede greater and faster progress against cancer include the inherent biological properties of tumors; the difficulties of developing new ways to prevent, diagnose and treat cancers; and economic and social factors that slow the nation’s cancer research efforts

  • Kidneys and adrenal glands in cartoon illustration
    Rare cancers yield potential source of tumor growth
    NIH Press Release

    (Posted: 09/17/2012) - Researchers at the National Institutes of Health have discovered a genetic mutation that appears to increase production of red blood cells in tumors. The discovery, based on analysis of tissue from rare endocrine tumors, may help clarify how some tumors generate a new blood supply to sustain their growth, the researchers explained.

  • Box of colored bars, depicting genes identified by TCGA for association with methylation (blue) or mutation (purple) in squamous lung cancer
    TCGA discovers potential therapeutic targets for lung squamous cell carcinoma
    NCI Press Release

    (Posted: 09/10/2012) - After sequencing the genomes of nearly 200 patients, researchers from The Cancer Genome Atlas initiative have identified potential therapeutic targets in lung squamous cell carcinoma, the second most common form of lung cancer. In the image above, squamous lung cancer subtypes are grouped into four columns. The horizontal rows depict genes identified by TCGA and how they differ by subtype.

  • Microscopic view of prostate cancer cells, stained purple and red, with red showing where Schlafen-11 is located in the nucleus
    Gene identified that sensitizes cancer cells to chemotherapy drugs
    NCI News Note

    (Posted: 08/27/2012) - NCI scientists have found that a gene, Schlafen-11 (SLFN11), sensitizes cells to substances known to cause irreparable damage to DNA.  As part of their study, the researchers used a repository of 60 cell types to identify predictors of cancer cell response to classes of DNA damaging agents, widely used as chemotherapy treatments for many cancers.

  • Blond woman physician in white lab coat examines two digital mammogram images on side-by-side flat screen monitors
    Breast cancer patients with high density mammograms do not have increased risk of death
    NCI Press Release

    (Posted: 08/20/2012) - High mammographic breast density, which is a marker of increased risk of developing breast cancer, does not seem to increase the risk of death among breast cancer patients, according to a study led by Gretchen L. Gierach, Ph.D., NCI. In the image above, a physician examines a digital mammogram of a dense breast and points to a potential tumor.

  • Burkitt lymphoma cells stained purple
    NIH study shows Burkitt lymphoma is molecularly distinct from other lymphomas
    NCI Press Release

    (Posted: 08/13/2012) - Scientists have uncovered a number of molecular signatures in Burkitt lymphoma, including unique genetic alterations that promote cell survival, that are not found in other lymphomas. These findings provide the first genetic evidence that Burkitt lymphoma is a cancer fundamentally distinct from other types of lymphoma.

  • Study shows colon and rectal tumors constitute a single type of cancer; The Cancer Genome Atlas generates genomic data for colon and rectal cancers that point to potential targets for treatment
    NCI Press Release

    (Posted: 07/18/2012) - The pattern of genomic alterations in colon and rectal tissues is the same regardless of anatomic location or origin within the colon or the rectum, leading researchers to conclude that these two cancer types can be grouped as one, according to The Cancer Genome Atlas (TCGA) project's large-scale study of colon and rectal cancer tissue specimens.

  • NIH tools facilitate matching cancer drugs with gene targets
    NCI Press Release

    (Posted: 07/16/2012) - A new study details how a suite of web-based tools provides the research community with greatly improved capacity to compare data derived from large collections of genomic information against thousands of drugs. By comparing drugs and genetic targets, researchers can more easily identify pharmaceuticals that could be effective against different forms of cancer.The newly updated software, called CellMiner, was built for use with the NCI-60, one of the most widely utilized collections of cancer cell samples employed in the testing of potential anti-cancer drugs

1 2 3 4 5 6 7 8 9 10  Next >